Mark S. Cooper

10.1k total citations · 2 hit papers
135 papers, 7.2k citations indexed

About

Mark S. Cooper is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Orthopedics and Sports Medicine. According to data from OpenAlex, Mark S. Cooper has authored 135 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Molecular Biology and 18 papers in Orthopedics and Sports Medicine. Recurrent topics in Mark S. Cooper's work include Adrenal Hormones and Disorders (64 papers), Hormonal Regulation and Hypertension (53 papers) and Estrogen and related hormone effects (15 papers). Mark S. Cooper is often cited by papers focused on Adrenal Hormones and Disorders (64 papers), Hormonal Regulation and Hypertension (53 papers) and Estrogen and related hormone effects (15 papers). Mark S. Cooper collaborates with scholars based in United Kingdom, Australia and United States. Mark S. Cooper's co-authors include Paul M. Stewart, Rowan Hardy, Martin Hewison, Markus J. Seibel, Elizabeth A. Walker, Gareth G. Lavery, Jeremy Tomlinson, Iwona Bujalska, Hong Zhou and Neil Gittoes and has published in prestigious journals such as New England Journal of Medicine, Cell and The Lancet.

In The Last Decade

Mark S. Cooper

131 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

11β-Hydroxysteroid Dehydrogenase Type 1: A Tissue-Specific Regulator of Glucocorticoid Response

2004 801 citations Jeremy Tomlinson, Gareth G. Lavery et al. profile →
Corticosteroid Insufficiency in Acutely Ill Patients

2003 706 citations Mark S. Cooper, Paul M. Stewart profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Cooper United Kingdom	42	3.5k	1.4k	1.0k	884	715	135	7.2k
Annemieke Verstuyf Belgium	44	1.0k 0.3×	1.7k 1.2×	477 0.5×	680 0.8×	801 1.1×	173	9.1k
Gherardo Mazziotti Italy	50	5.3k 1.5×	1.8k 1.3×	1.5k 1.5×	1.0k 1.1×	1.7k 2.4×	211	8.9k
Barbara Obermayer‐Pietsch Austria	49	1.6k 0.4×	2.2k 1.5×	822 0.8×	718 0.8×	2.2k 3.0×	259	8.6k
John G. Haddad United States	49	1.4k 0.4×	1.1k 0.8×	735 0.7×	603 0.7×	1.7k 2.4×	141	8.7k
S. Raptis Greece	45	2.3k 0.7×	1.3k 0.9×	1.9k 1.9×	1.3k 1.5×	155 0.2×	231	6.9k
Alfredo Pontecorvi Italy	52	5.7k 1.6×	2.6k 1.8×	2.9k 2.8×	1.1k 1.3×	169 0.2×	437	10.7k
Alexander J. Howie United Kingdom	40	956 0.3×	1.4k 1.0×	623 0.6×	383 0.4×	180 0.3×	132	5.8k
Marco Boscaro Italy	60	9.5k 2.7×	1.6k 1.1×	5.0k 4.9×	941 1.1×	142 0.2×	336	13.6k
Otto Mehls Germany	54	2.3k 0.6×	1.9k 1.3×	1.5k 1.4×	536 0.6×	356 0.5×	319	10.6k
Trond Jenssen Norway	42	2.0k 0.6×	815 0.6×	2.1k 2.1×	753 0.9×	152 0.2×	187	6.5k

Countries citing papers authored by Mark S. Cooper

Since Specialization

Citations

This map shows the geographic impact of Mark S. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Cooper more than expected).

Fields of papers citing papers by Mark S. Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Cooper. The network helps show where Mark S. Cooper may publish in the future.

Co-authorship network of co-authors of Mark S. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Cooper. A scholar is included among the top collaborators of Mark S. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Cooper. Mark S. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cooper, Mark S., Sean Goggins, Steven Reynolds, et al.. (2025). Development of p300-targeting degraders with enhanced selectivity and onset of degradation. RSC Medicinal Chemistry. 16(5). 2049–2060. 1 indexed citations

Mahida, Rahul Y., Siân Lax, Christopher Bassford, et al.. (2023). Impaired alveolar macrophage 11β-hydroxysteroid dehydrogenase type 1 reductase activity contributes to increased pulmonary inflammation and mortality in sepsis-related ARDS. Frontiers in Immunology. 14. 1159831–1159831. 9 indexed citations

Bosnakovski, Darko, Elizabeth T. Ener, Mark S. Cooper, et al.. (2021). Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma. Oncogenesis. 10(10). 68–68. 21 indexed citations

Cooper, Mark S., et al.. (2021). Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe. Frontiers in Endocrinology. 12. 733611–733611. 15 indexed citations

Fenton, Chloe, Craig Doig, Amy J. Naylor, et al.. (2019). 11β-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy. Arthritis Research & Therapy. 21(1). 188–188. 32 indexed citations

Fenton, Chloe, J. Matthew Webster, Corinna Wehmeyer, et al.. (2019). Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis. Arthritis Research & Therapy. 21(1). 182–182. 26 indexed citations

Kim, Sarah, et al.. (2018). Comparison of blood sampling methods for plasma corticosterone measurements in mice associated with minimal stress-related artefacts. Steroids. 135. 69–72. 30 indexed citations

Tu, Jinwen, Yaqing Zhang, Sarah Kim, et al.. (2016). Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts Attenuates Joint Inflammation in Collagen Antibody–Induced Arthritis. American Journal Of Pathology. 186(5). 1293–1301. 12 indexed citations

Nanus, Dominika E., Andrew Filer, Lorraine Yeo, et al.. (2015). Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis. Arthritis Research & Therapy. 17(1). 121–121. 12 indexed citations

10.

Doig, Craig, et al.. (2014). TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle. Journal of Endocrinology. 220(3). 389–396. 5 indexed citations

11.

Juárez, Maria, Emmanuel Karouzakis, Rowan Hardy, et al.. (2013). Early rheumatoid arthritis and resolving fibroblasts segregate according to Dickkopf related protein 1 expression. The Lancet. 381. S57–S57. 2 indexed citations

12.

Seibel, Markus J., Mark S. Cooper, & Hong Zhou. (2013). Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. The Lancet Diabetes & Endocrinology. 1(1). 59–70. 157 indexed citations

13.

Tiganescu, Ana, et al.. (2012). Reversal of age-induced dermal atrophy in 11[beta]-hydroxysteroid dehydrogenase type 1-null mice. 28. 1 indexed citations

14.

Hardy, Rowan, Christopher M. Jones, Dominika E. Nanus, et al.. (2012). Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells. Arthritis & Rheumatism. 64(7). 2404–2413. 41 indexed citations

15.

Pablo, Paola de, Mark S. Cooper, & Christopher D. Buckley. (2012). Association between bone mineral density and C‐reactive protein in a large population‐based sample. Arthritis & Rheumatism. 64(8). 2624–2631. 66 indexed citations

16.

Sedeek, Mona, Augusto C. Montezano, Richard Hébert, et al.. (2012). Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies. Journal of Cardiovascular Translational Research. 5(4). 509–518. 97 indexed citations

17.

Hardy, Rowan, Marco Eijken, Johannes P.T.M. van Leeuwen, et al.. (2009). Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss. Annals of the Rheumatic Diseases. 69(6). 1185–1190. 53 indexed citations

18.

Cooper, Mark S., Holly Syddall, Caroline Fall, et al.. (2005). Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study. Clinical Endocrinology. 62(6). 692–697. 42 indexed citations

19.

Fink, Rachel & Mark S. Cooper. (1996). Apical Membrane Turnover Is Accelerated Near Cell–Cell Contacts in an Embryonic Epithelium. Developmental Biology. 174(2). 180–189. 24 indexed citations

20.

Cooper, Mark S. & Geoffrey Allen. (1959). The effect of chlortetracycline on the immune response. II. Influence on development of protective antibodies after vaccination with a live, avirulent strain of Erysipelothrix rhusiopathiae.. PubMed. 83. 232–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact